PDCI

PDCI is an alliance of pharmaceutical companies, NGOs, WHO, donors, and other partners collaborating on drug donation programs for neglected tropical diseases (NTDs). PDCI provides a forum for stakeholders to share best practices, information, and experiences and to discuss tools and strategies to improve access to essential medicines for populations affected by NTDs. The Role of the Partnership for Disease Control Initiatives (PDCI) Collaboration among PDCI members creates synergies, ensures safe mass drug administration, and helps reduce the financial and human resources burden on communities and health systems.

PDCI works together to:

Provide essential medicines free of charge for neglected tropical diseases;
Support the control and/or elimination of NTDs by providing safe and effective drugs suitable for mass distribution;
Build capacity with sustainable distribution strategies designed to enable the people most directly affected to determine their own needs and priorities;
Address complex health problems in the developing world that require innovative solutions through public-private partnerships;
Establish clear objectives, trust, transparency, complementary expertise and mutual benefit among the partners;
Ensure the ongoing communication, coordination, collaboration, and commitment of all stakeholders;
Enhance the drug donations with support for operational research, field activities such as IEC and program implementation, monitoring and surveillance, and morbidity management.

To ensure effective coordination and integration of these drug donation programs and to build effective partnerships and identify potential for synergies, PDCI meets twice a year to discuss topics including:

Research needs to ensure the safe co-administration of drug interventions for NTDs;
Coordination and integration of drug interventions to ensure safe and effective delivery of preventive chemotherapy;
Monitoring and evaluation and measuring the impact of drug donation programs;
Operational and logistics issues – supply chain, distribution mechanisms, infrastructure;
Manufacturing capacity to meet demand as NTD control programs scale up.